Hls Therapeutics Usa Inc

FDA Filings

This page includes the latest FDA filings for Hls Therapeutics Usa Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

FDA Filings

Device Company	Device	Date
Clozaril HLS Therapeutics (USA), Inc.	Prescription Medication	2025-02-02
Clozaril HLS Therapeutics (USA), Inc.	Prescription Medication	2024-11-27
Clozaril HLS Therapeutics (USA), Inc.	Prescription Medication	2024-10-06
Clozaril HLS Therapeutics (USA), Inc.	Prescription Medication	2024-07-06
Clozaril HLS Therapeutics (USA), Inc.	Prescription Medication	2023-05-30
Clozaril HLS Therapeutics (USA), Inc.	Prescription Medication	2023-01-05
Clozaril HLS Therapeutics (USA), Inc.	Prescription Medication	2021-03-19
Clozaril HLS Therapeutics (USA), Inc.	Prescription Medication	2021-03-11
Clozaril HLS Therapeutics (USA), Inc.	Prescription Medication	2020-03-19
Clozaril HLS Therapeutics (USA), Inc.	Prescription Medication	2020-01-08
NDC 69809-0135 HLS Therapeutics (USA), Inc.	Clozaril	2019-12-17
NDC 69809-0130 HLS Therapeutics (USA), Inc.	Clozaril	2019-12-17
Clozaril HLS Therapeutics (USA), Inc.	Prescription Medication	2018-01-26
NDC 69809-0127 HLS Therapeutics (USA), Inc.	Clozaril	2016-05-06
NDC 69809-0126 HLS Therapeutics (USA), Inc.	Clozaril	2016-05-06

Similar & Related FDA Registered Companies

Related Finance Registrations

NCAGE Code	7H5Q7	HLS THERAPEUTICS (USA), INC.
CAGE Code	7H5Q7	HLS THERAPEUTICS (USA), INC.
S.A.M. Registration	7H5Q7 [79808066]	HLS THERAPEUTICS (USA), INC.

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.